Navigation Links
TheraVasc Releases Phase I Trial Data Demonstrating Safety of Drug in Diabetic Patients
Date:9/20/2011

CLEVELAND, Sept. 20, 2011 /PRNewswire/ -- TheraVasc (www.theravasc.com) announced the successful completion of a Phase I clinical trial of a drug, TV1001, to diabetic patients. The trial included 12 diabetic patients who each received a single dose of two different oral formulations of TV1001, an enteric coated and a non-enteric coated capsule, to determine safety and blood levels of the drug.  Based on prior studies conducted in animals, the circulating blood levels in all patients were in the range believed to be therapeutic.

"Many of the patients treated in this study have severe chronic wounds for which no effective treatments are available. Based on the safety of the drug we observed in this study and the ability to achieve a therapeutic benefit in animals at the dose tested in this study, this drug offers hope that someday we might have a way of effectively treating these diabetic ulcers," said Dr. Frank Greenway, the Principal Investigator of the Study and Director of the Outpatient Clinic at the Pennington Biomedical Research Center.

Few adverse events were reported during the trials and there was no significant increase in methemoglobin levels, which would have prevented the release of oxygen in the blood, at the dose tested, the most likely adverse event associated with the treatment.  

TheraVasc's previously conducted animal studies using TV1001 showed that when taken chronically, similar blood levels resulted in the generation of new blood vessels in oxygen-deprived limbs, improvement in wound healing, and inhibition of tissue necrosis. The company expects to complete Phase IIa trials in mid-2012 in which the safety of multiple doses of chronically administered TV1001 will be assessed, along with testing for evidence of biological activity.

TheraVasc is initially developing TV1001 as a treatment for diabetic patients with Peripheral Arterial Disease (PAD), a condition affec
'/>"/>

SOURCE TheraVasc Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
2. CEL-SCI Corporation Releases Letter to Shareholders
3. AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel
4. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
5. Immunosyn Corporation Releases SF-1019 Study Results
6. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
7. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
8. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
9. CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence
10. QRxPharma Releases Additional Phase 3 Data for Q8003IR Dual Opioid Pain Therapy
11. Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine (MSI-1436) at CBI Obesity Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... July 29, 2014 Apex Medical Corporation (Apex, TWSE: ... Area Care sectors, announces that it is appealing the judgment ... in Germany that found the headgear ... that it has initiated invalidity challenges against various ResMed patents ... counterattacking against trivial and junk patents. ResMed ...
(Date:7/29/2014)... SAN DIEGO , July 29, 2014 /PRNewswire/ ... of Nancy Thornberry to its board ... and franchise head, Diabetes and Endocrinology for Merck ... research, strategy and overall pipeline management in diabetes, ... scientist, initiated and co-led the program that resulted ...
(Date:7/29/2014)... July 29, 2014  Encision Inc. (OTCQB:ECIA), a medical ... stray electrosurgical burns in minimally invasive surgery, today announced ... June 30, 2014. The Company posted quarterly ... loss of $202 thousand, or $(0.02) per share. These ... a net loss of $311 thousand, or $(0.04) per ...
Breaking Medicine Technology:Apex Continues Fighting Against Patents to Free Up Competition 2Abide Therapeutics Appoints Nancy Thornberry to Board of Directors 2Abide Therapeutics Appoints Nancy Thornberry to Board of Directors 3Encision Reports First Quarter Fiscal Year 2015 Results 2Encision Reports First Quarter Fiscal Year 2015 Results 3Encision Reports First Quarter Fiscal Year 2015 Results 4
... CHENGDU, China , May 7 /PRNewswire-Asia-FirstCall/ -- Tianyin,Pharmaceutical ... and sells modernized traditional Chinese medicine,("TCM") and branded generics based in ... call to discuss its fiscal 2010 third,quarter results at 9:00 a.m. ... , , ...
... Hill-Rom Holdings, Inc. (NYSE: HRC ) today announced its fiscal 2010 third quarter ... on May 6, 2010 , and is payable on June 30, 2010 , to ... , , ... , Hill-Rom is a leading ...
Cached Medicine Technology:Tianyin Pharmaceutical Co., Inc. to Host Third Fiscal Quarter 2010 Results Earnings Conference Call on Wednesday, May 12, 2010 at 9:00 a.m. ET 2Tianyin Pharmaceutical Co., Inc. to Host Third Fiscal Quarter 2010 Results Earnings Conference Call on Wednesday, May 12, 2010 at 9:00 a.m. ET 3
(Date:7/29/2014)... 29, 2014 CRN International has promoted ... Operation. , Christina Upton, an 11-year veteran at the ... Services responsible for managing the day-to-day execution of all ... the center of all activities for CRN clients, which ... the world . The department interfaces directly with clients, ...
(Date:7/29/2014)... 2014 Healthcare staffing agency Medical ... of Tomorrow Scholarship Competition winners:, , ... ,     Racheal D., Freshman, Cerritos College in ... Community College in Houston, TX , ... Solutions hosts the Nurses of Tomorrow Scholarship competition ...
(Date:7/29/2014)... July 29, 2014 1WorldSync announces ... leading healthcare suppliers will utilize the Global Data ... information network to share product information with the ... trading partners across their global supply chain. Holger ... at B. Braun: "B. Braun serves customers in ...
(Date:7/29/2014)... Burlington, VT (PRWEB) July 29, 2014 ... image management solutions, announced today the release of ... Portal, version 11.5. , Mach7’s Physician & ... physicians and patients. Patients gain access to a ... imaging files. Mach7 seamlessly consolidates complete patient care ...
(Date:7/29/2014)... Collierville, TN (PRWEB) July 29, 2014 ... to the reimbursement model of all hospitals. Studies show ... tsunami.[1] One simple, easy, low cost tool that ... organizational performance by 20 to 25%. , Their secret? ... to one anther at the end of an operational ...
Breaking Medicine News(10 mins):Health News:CRN International Names New Director to Lead Client Services Department 2Health News:Medical Solutions Announces Nurses of Tomorrow Scholarship Winners 2Health News:B. Braun Selects 1WorldSync Unique Device Identification and Product Information Solution 2Health News:B. Braun Selects 1WorldSync Unique Device Identification and Product Information Solution 3Health News:Mach7 Technologies’ Physician & Patient Portal Consolidates Patient Care Records across the Enterprise and Simplifies Image Sharing and Communication 2Health News:Mach7 Technologies’ Physician & Patient Portal Consolidates Patient Care Records across the Enterprise and Simplifies Image Sharing and Communication 3Health News:One Brilliant Economic Survival Tool You Can Steal from the World's Best Hospitals 2Health News:One Brilliant Economic Survival Tool You Can Steal from the World's Best Hospitals 3
... , , , , ... Fire Department, will attempt to set the Ohio state record for ... Lebanon, Ohio on September 4, 2009. His mission: To memorialize the ... create awareness about education that exists to prevent these unnecessary deaths. ...
... , MINNEAPOLIS, Sept. 3 ... company that develops, manufactures and markets innovative proprietary products to ... 2009 edition of THE JOURNAL OF UROLOGY(R) from the OrBIT ... is a proprietary, minimally invasive percutaneous tibial nerve stimulation (PTNS) ...
... ... ... September 3, 2009 -- FaxBack®, a leading provider of reliable VoIP fax server solutions ... ATA device, based on HTTPS, which provides a superior level of reliability for VoIP faxes. ...
... ... have entered a partnership to provide TDA members with accounts receivable management services from ... , ... 3, 2009 -- The Texas Dental Association (TDA) has partnered with TekCollect , ...
... ... Studies Personality Traits along with Gender and Generational Differences , ... Alpharetta, GA (Vocus) September 3, 2009 -- ... to dominant personality traits? Jackson & Coker has begun a year-long research study ...
... ... of leading B2B online comparison shopping marketplaces, today announced that 98% of customers would ... profession. , ... NC (PRWEB) September 3, 2009 -- Net32 today reported that dentists have provided the ...
Cached Medicine News:Health News:Firefighter Will Attempt to Set Ohio Record for 100 Consecutive Skydives 2Health News:Firefighter Will Attempt to Set Ohio Record for 100 Consecutive Skydives 3Health News:Published Study Shows More Patients See Improvement in Overactive Bladder Symptoms With Urgent(R) PC Device Compared to Those Using a Drug 2Health News:Published Study Shows More Patients See Improvement in Overactive Bladder Symptoms With Urgent(R) PC Device Compared to Those Using a Drug 3Health News:Published Study Shows More Patients See Improvement in Overactive Bladder Symptoms With Urgent(R) PC Device Compared to Those Using a Drug 4Health News:FaxBack Announces a New VoIP Fax ATA, based on HTTPS, Which Provides a Level of Quality for VoIP Faxing Equal to PSTN Connections 2Health News:Texas Dental Association Offers Premier Accounts Receivable Management Services from TekCollect via TDA Perks Program 2Health News:Physicians' Personalities Provide Clues Regarding Job Satisfaction 2Health News:Physicians' Personalities Provide Clues Regarding Job Satisfaction 3Health News:Physicians' Personalities Provide Clues Regarding Job Satisfaction 4Health News:Net32, Inc. Reports Highest Customer Ratings Ever 2
Used in conjunction with the E5381 600 Circling Band (40 style). Indications: When high buckle is required. Overall length: 14.0 mm....
Concave inner surface to conform to the globe. Used in conjunction with the E5381 600 Circling Band (40 style). Indications: Wide scleral bed. Outside diameter 30.2 mm....
...
...
Medicine Products: